Breaking News, Financial News

Financial Report: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 4Q Revenues: $47.2 million (+1%) 4Q Loss: $844,000 (loss of $764,000 in 4Q2006) FY Revenues: $192.5 million (+7%) FY Earnings: $8.9 million (earnings were $2.2 million FY2006) Comments: Total contract and milestone revenue for the quarter was $41.1 million (+2%) and for the year was $165.5 million (+8%). Milestone revenue for the year was $2.1 million, which includes $1.5 million resulting from the company’s collaborative research agreement with Bristol-Myers Squibb. Develop...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters